Otizm Spektrum Bozukluğu Patogenezi

Williams RS, Hauser SL, Purpura DP, DeLong GR, Swisher CN. Autism and mental retardation: neuropathologic studies performed in four retarded persons with autistic behavior. Arch Neurol, 1980. 37(12): p. 749-53.

Geschwind, D.H. and P. Levitt, Autism spectrum disorders: developmental disconnection syndromes. Curr Opin Neurobiol, 2007. 17(1): p. 103-11.

Jiang CC, Lin LS, Long S, Ke XY, Fukunaga K, Lu YM, Han F. Signalling pathways in autism spectrum disorder: mechanisms and therapeutic implications. Signal Transduct Target Ther, 2022. 7(1): p. 229.

Sauer AK, Stanton JE, Hans S, Grabrucker AM. Autism Spectrum Disorders: Etiology and Pathology, in Autism Spectrum Disorders, A.M. Grabrucker, Editor. 2021: Brisbane (AU).

Nisar, S., Ajaz AB., Masoodi T.,et al. Genetics of glutamate and its receptors in autism spectrum disorder. Mol Psychiatry, 2022. 27(5): p. 2380-2392.

Hussein Y., Tripathi U., Choudhary A., et al. Early maturation and hyperexcitability is a shared phenotype of cortical neurons derived from different ASD-associated mutations. Translational Psychiatry, 2023, 13.1: 246.

Förster E, Jossin Y, Zhao S, Chai X, Frotscher M, Goffinet AM., Recent progress in understanding the role of Reelin in radial neuronal migration, with specific emphasis on the dentate gyrus. Eur J Neurosci, 2006. 23(4): p. 901-9.

Kelemenova S, Ostatnikova D. Neuroendocrine pathways altered in autism. Special role of reelin. Neuro Endocrinol Lett, 2009, 30.4: 429-36.

Pejhan, S. and M. Rastegar, Role of DNA Methyl-CpG-Binding Protein MeCP2 in Rett Syndrome Pathobiology and Mechanism of Disease. Biomolecules, 2021. 11(1).

Cheon, S., M. Dean, and M. Chahrour, The ubiquitin proteasome pathway in neuropsychiatric disorders. Neurobiol Learn Mem, 2019. 165: p. 106791.

Zhuang, Hongbin, Liang Z, et al. Autism spectrum disorder: pathogenesis, biomarker, and intervention therapy. MedComm, 2024, 5.3: e497.

Herman GE, Butter E, Enrile B, Pastore M, Prior TW, Sommer A. Increasing knowledge of PTEN germline mutations: Two additional patients with autism and macrocephaly. Am J Med Genet Part A 2006, 143A:589–593.

Kwan, V., B.K. Unda, and K.K. Singh, Wnt signaling networks in autism spectrum disorder and intellectual disability. J Neurodev Disord, 2016. 8: p. 45.

Wu S, Wu F, Ding Y, Hou J, Bi J, Zhang Z., Advanced parental age and autism risk in children: a systematic review and meta-analysis. Acta Psychiatr Scand, 2017. 135(1): p. 29-41.

Byars, S.G. and J.J. Boomsma, Opposite differential risks for autism and schizophrenia based on maternal age, paternal age, and parental age differences. Evol Med Public Health, 2016. 2016(1): p. 286-98.

Rieske, R.D. and J.L. Matson, Parental Age at Conception and the Relationship with Severity of Autism Symptoms. Dev Neurorehabil, 2020. 23(5): p. 265-270.

Yenkoyan K, Mkhitaryan M, Bjørklund G. Environmental Risk Factors in Autism Spectrum Disorder: A Narrative Review. Curr Med Chem.,2024 .31(17):2345-2360.

Usui N, Kobayashi H, Shimada S. Neuroinflammation and Oxidative Stress in the Pathogenesis of Autism Spectrum Disorder. Int J Mol Sci, 2023. 24(6):5487.

Shi L, Fatemi SH, Sidwell RW, Patterson PH. Maternal influenza infection causes marked behavioral and pharmacological changes in the offspring. J Neurosci, 2003. 23(1):297-302.

Meltzer A, Van de Water J. The Role of the Immune System in Autism Spectrum Disorder. Neuropsychopharmacology, 2017. 42(1):284-298.

Velloso FJ, Zaritsky R, Houbeika RY, Rios N, Levison SW. Interleukin-6 produces behavioral deficits in pre-pubescent mice independent of neuroinflammation. Brain Behav Immun. 2025 Feb 19;126:275-288.

Meador, K.J. Fetal antiepileptic drug exposure and cognitive outcomes at age 6 years (NEAD study): a prospective observational study. Lancet Neurol, 2013. 12(3): p. 244-52.

Hernandez-Diaz, S., Straub L., Bateman BT. et al., Risk of Autism after Prenatal Topiramate, Valproate, or Lamotrigine Exposure. N Engl J Med, 2024. 390(12): p. 1069-1079.

Brown HK., Hussain-Shamsy N., Lunsky Y., Dennis CE., Simone N Vigod . The Association Between Antenatal Exposure to Selective Serotonin Reuptake Inhibitors and Autism: A Systematic Review and Meta-Analysis. J Clin Psychiatry, 2017. 78(1): p. e48-e58.

Liu, X., Agerbo E., Ingstrup KG., et al. Antidepressant use during pregnancy and psychiatric disorders in offspring: Danish nationwide register based cohort study. BMJ, 2017. 358: p. j3668.

Gidaya NB, Lee BK, Burstyn I, Michael Y, Newschaffer CJ, Mortensen EL. In utero Exposure to β-2-Adrenergic Receptor Agonist Drugs and Risk for Autism Spectrum Disorders. Pediatrics, 2016. 137(2):e20151316.

Yin, W., Pulakka A., Reichenberg A., et al., Association between parental psychiatric disorders and risk of offspring autism spectrum disorder: a Swedish and Finnish population-based cohort study. Lancet Reg Health Eur, 2024. 40: p. 100902.

Bauman, M.L. and T.L. Kemper, Neuroanatomic observations of the brain in autism: a review and future directions. Int J Dev Neurosci, 2005. 23(2-3): p. 183-7.

Juranek, J., Filipek PA, Berenji GR, Modahl C, Osann K, Spence MA, Association between amygdala volume and anxiety level: magnetic resonance imaging (MRI) study in autistic children. J Child Neurol, 2006. 21(12): p. 1051-8.

Courchesne, E., Karns CM, Davis HR., et al., Unusual brain growth patterns in early life in patients with autistic disorder: an MRI study. Neurology, 2001. 57(2): p. 245-54.

Courchesne, E., Mouton PT., Calhoun ME.,et al., Neuron number and size in prefrontal cortex of children with autism. JAMA, 2011. 306(18): p. 2001-10.

22. Badhe, S. Abnormal Development of the Corpus Callosum in Autism Spectrum Disorder: An MRI Study. Top Magn Reson Imaging, 2024. 33(3): p. e0312.

Baizer, J.S., Neuroanatomy of autism: what is the role of the cerebellum? Cereb Cortex, 2024. 34(13): p. 94-103.

Sydnor, L.M. and K.A. Aldinger, Structure, Function, and Genetics of the Cerebellum in Autism. J Psychiatr Brain Sci, 2022. 7.

Pardo, C.A. and C.G. Eberhart, The neurobiology of autism. Brain Pathol, 2007. 17(4): p. 434-47.

Dedeoğlu Ö., Çetinkaya M., Derinkuyu BE., et al. Aspects of autism spectrum disorder and correlation with neuroimaging findings in tuberous sclerosis complex. Clinical Neurology and Neurosurgery, 2023. 224: 107550.

Rojas DC, Singel D, Steinmetz S, Hepburn S, Brown MS. Decreased left perisylvian GABA concentration in children with autism and unaffected siblings. Neuroimage, 2014 . 86:28-34.

Horder, J. Glutamate and GABA in autism spectrum disorder-a translational magnetic resonance spectroscopy study in man and rodent models. Transl Psychiatry, 2018. 8(1): p. 106.

Blatt JG ,Fatemi SH. Alterations in GABAergic biomarkers in the autism brain: research findings and clinical implications. Anat. Rec. , 2011. 294, 1646–1652.

Rodnyy AY, Kondaurova EM, Tsybko AS, Popova NK, Kudlay DA, Naumenko VS. The brain serotonin system in autism. Rev Neurosci.2023. 35(1):1-20.

Schain RJ, Freedmann DX. Studies on 5-hydroxyindole metabolism in autistic and other mentally retarded children. J Pediatr. 1961 Mar ve 58:315-20.

Leboyer M, Philippe A, Bouvard M, et al. Whole blood serotonin and plasma beta-endorphin in autistic probands and their first-degree relatives. Biol Psychiatry, 1999.

Pourhamzeh M, Moravej FG, Arabi M, et al. The Roles of Serotonin in Neuropsychiatric Disorders. Cell Mol Neurobiol. 2022 .42(6):1671-1692.

Spivak B, Golubchik P, Mozes T, et al. Low platelet-poor plasma levels of serotonin in adult autistic patients. Neuropsychobiology, 2004 .50(2):157-60.

Hernández-del Caño C, Varela-Andrés N, Cebrián-León A, Deogracias R. Neurotrophins and Their Receptors: BDNF’s Role in GABAergic Neurodevelopment and Disease. International Journal of Molecular Sciences, 2024. 25(15):8312.

Steeb H, Ramsey JM, Guest PC. et al. Serum proteomic analysis identifies sex-specific differences in lipid metabolism and inflammation profiles in adults diagnosed with Asperger syndrome. Molecular autism, 2014, 5: 1-10

Lai M-C, Lombardo MV, Auyeung B, Chakrabarti B, Baron-Cohen S. Sex/ gender differences and autism: setting the scene for future research. J Am Acad Child Adolesc Psychiatry. 2015;54:11.

Fröhlich H, Kollmeyer ML, Linz VC, et al. Gastrointestinal dysfunction in autism displayed by altered motility and achalasia in Foxp1 +/− mice. Proc Natl Acad Sci USA. 2019.116(44):22237–45.

Wang LW, Tancredi DJ, Thomas DW. The prevalence of gastrointestinal problems in children across the United States with autism spectrum disorders from families with multiple affected members. J Dev Behav Pediatr. 2011. 32(5):351–60.

Ruskin DN, Svedova J, Cote JL, et al. Ketogenic diet improves core symptoms of autism in BTBR mice. PLoS One, 2013.8(6):e65021.

Maalouf M, Rho JM, Mattson MP. The neuroprotective properties of calorie restriction, the ketogenic diet, and ketone bodies. Brain Res Rev. 2009. 59:293–315.